Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF) · 3 months ago
Inside Sales Pharmaceutical Representative
Cipher Pharmaceuticals Inc. is a pharmaceutical company seeking an Inside Sales Pharmaceutical Representative. The role involves making outbound calls to healthcare professionals, delivering sales presentations, and adhering to legal requirements while maximizing sales potential within an assigned territory.
Responsibilities
Make outbound calls to healthcare professionals (HCPs) to share product information, gather insights, and support ongoing engagement efforts
Professionally represent Cipher Pharmaceuticals, delivering sales presentations to HCPs in accordance with company SOPs and sales training
Adhere to all legal and regulatory requirements governing the promotion and sale of pharmaceutical products
Develop and execute a business plan to maximize sales potential within the assigned territory
Successfully complete Cipher's comprehensive sales training program
Build and maintain quality relations with assigned accounts
Evaluate and adjust performance to increase prescription sales
Maintain updated and organized account files through contact management
Complete and maintain call reports in compliance with company policy
Perform other related duties as assigned
Qualification
Required
College/University degree
Must live within 30 miles of headquarters with reliable transportation to and from work
Must pass company security and background checks
Excellent verbal and written communication
Strong problem-solving and analytical skills
Proficiency in computers and digital tools
Ability to lift packages of up to 25 pounds
Preferred
Sales experience with a proven track record is a plus
Company
Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX:CPHRF)
Cipher Pharmaceuticals (TSX: CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products.
Funding
Current Stage
Public CompanyTotal Funding
$55MKey Investors
Royal Bank of CanadaCIBC
2023-03-01Post Ipo Debt· $35M
2017-11-03Post Ipo Debt· $20M
2014-11-24IPO
Recent News
2025-11-07
Company data provided by crunchbase